Vascular Access Complications for Therapeutic Apheresis in Nephrology

NCT05894317 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2025-02-24

No results posted yet for this study

Summary

The aim of this study is to describe vascular access complications which are used for therapeutic apheresis in Nephrology.

Conditions

  • Vascular Access Complication
  • Apheresis Related Complication

Sponsors & Collaborators

  • Central Hospital, Nancy, France

    lead OTHER

Principal Investigators

  • Luc Frimat, MD PhD · CHRU NANCY DRCI

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-06-01
Primary Completion
2022-06-30
Completion
2025-02-14

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05894317 on ClinicalTrials.gov